Roeland Nusse - Aug 23, 2021 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Director
Signature
/s/ Brenda S. Furlow as Attorney-in-Fact for Roeland Nusse pursuant to Power of Attorney previously filed.
Stock symbol
TECH
Transactions as of
Aug 23, 2021
Transactions value $
-$1,644,665
Form type
4
Date filed
8/25/2021, 05:13 PM
Next filing
Nov 1, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Options Exercise $281K +4K +59.13% $70.35 10.8K Aug 23, 2021 Direct
transaction TECH Common Stock Sale -$1.93M -4K -37.16% $481.52* 6.77K Aug 23, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Stock Option (right to buy) Options Exercise $0 -4K -100% $0.00* 0 Aug 23, 2021 Common Stock 4K $70.35 Direct
holding TECH Stock Option (right to buy) 4K Aug 23, 2021 Common Stock 4K $87.39 Direct
holding TECH Stock Option (right to buy) 4K Aug 23, 2021 Common Stock 4K $91.78 Direct
holding TECH Stock Option (right to buy) 4.26K Aug 23, 2021 Common Stock 4.26K $87.34 Direct
holding TECH Stock Option (right to buy) 3.99K Aug 23, 2021 Common Stock 3.99K $101.19 Direct
holding TECH Stock Option (right to buy) 3.13K Aug 23, 2021 Common Stock 3.13K $125.05 Direct
holding TECH Stock Option (right to buy) 1.9K Aug 23, 2021 Common Stock 1.9K $179.84 Direct
holding TECH Stock Option (right to buy) 2.01K Aug 23, 2021 Common Stock 2.01K $201.64 Direct
holding TECH Stock Option (right to buy) 1.51K Aug 23, 2021 Common Stock 1.51K $255.69 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on the earlier of the one year anniversary of the grant date (10/29/2020) or the date of Bio-Techne's 2021 annual meeting of shareholders.